Malaria vaccines: where are we and where are we going?
Malaria is still killing over one million people each year and its incidence is increasing. The need for an effective vaccine is greater than ever. A major difficulty with vaccine research is that the malaria parasite presents thousands of antigens to the human immune system that vary throughout its life cycle. Identifying those that may prove to be vaccine targets is complicated and time consuming. Most vaccines are targeted at individual stages of the malaria life cycle, although it is likely that only the development of a multistage vaccine will offer complete protection to both visitors to, and residents of, a malaria-endemic area. With the development of a successful vaccine other issues such as cost, distribution, education, and compliance will have to be addressed. This review describes some of the current vaccine candidates for immunising against malaria.
Moore
Shirley A
SA
University of Aberdeen, Aberdeen, UK.
Surgey
Emma G E
EG
Cadwgan
Anthony M
AM
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology / Q000378:metabolism; D006801:Humans; D008018:Life Cycle Stages; D008288:Malaria / Q000276:immunology / Q000469:parasitology / Q000517:prevention & control*; D017780:Malaria Vaccines / Q000276:immunology*; D010961:Plasmodium / Q000254:growth & development / Q000276:immunology / Q000378:metabolism
D000953:Antigens, Protozoan; D017780:Malaria Vaccines